Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma

NCT01916187 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped drug company withdrew support following re-examination of benefit-risk assessment for the investigational use of imetelstat in this population

Conditions

Neuroblastoma

Interventions

DRUG: Imetelstat

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]